Bioequivalence and Wear Study of Mylan Fentanyl Transdermal System 25 µg/h and Mylan Fentanyl Transdermal System
Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
The objective of this study was primarily to investigate the bioequivalence and secondly to
assess the wearability (adhesion) and acute irritation of Mylan fentanyl transdermal system
with and without an overlay system following a single 25 µg/hr application worn for 72 hours.